Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Dow
QuintilesIMS
Express Scripts
Teva
Covington
Deloitte
AstraZeneca
Cipla

Generated: June 19, 2018

DrugPatentWatch Database Preview

KLARON Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Klaron patents expire, and when can generic versions of Klaron launch?

Klaron is a drug marketed by Valeant Pharms North and is included in one NDA.

The generic ingredient in KLARON is sulfacetamide sodium. There are three drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
Drug patent expirations by year for KLARON
Pharmacology for KLARON
Ingredient-typeSulfonamides
Drug ClassSulfonamide Antibacterial
Medical Subject Heading (MeSH) Categories for KLARON
Synonyms for KLARON
127-56-0
144-80-9 (Parent)
30760ZE777
AB00513796
AC-7629
AC1N2JI9
Acetamide, N-((4-aminophenyl)sulfonyl)-, sodium salt (1:1)
ACETAMIDE, N-SULFANILYL-, MONOSODIUM SALT
Acetamide, N-sulfanilyl-, N-sodium deriv
Acetamide, N-sulfanilyl-, sodium deriv
AKOS003281404
AKOS025402286
Albucid soluble
Albucid-Natrium
Albucide
Almocetamide
AN-23002
Antebor
API0004257
AS-13361
Beocid-isoptal
Blefamide
Bleph 10
C08051
Cetamide
CHEBI:9327
CHEMBL1200416
EINECS 204-848-4
Farmamid
FT-0631741
Galseptil
H994
HMS3652G10
J-005502
KS-0000129C
Locula
LT03330165
LT03381141
MFCD00007885
MFCD00149555
Minims sulphacetamide
MolPort-001-520-453
N-((4-Aminophenyl)sulfonyl)-acetamide monosodium salt
N-(4-Aminophenylsulfonyl)acetamide sodium salt
N-[(4-aminophenyl)sulfonyl]acetamide, sodium salt
N-Acetyl-4-aminobenzenesulfonamide Sodium Salt
N-Acetylsulfanilamide Sodium Salt
N-Sulfanilylacetamide sodium
N-Sulfanilylacetamide sodium salt
N-Sulfanilylacetamide, sodium salt
N(1)-acetylsulfanilamide sodium
N(1)-acetylsulfanilamide sodium salt
N(sup 1)-Acetylsulfanilamide sodium
N(sup 1)-Acetylsulfanilamide sodium salt
N1-Acetylsulfanilamide sodium
N1-Acetylsulfanilamide sodium salt
Oc-U-Mid
Octsetan
Opulets sulpjacetamide
OR011665
OR211673
PQMSFAORUFMASU-UHFFFAOYSA-M
Prontamid
S0578
s4081
SCHEMBL3051698
Sebizon lotion
Sodium Acetyl-(4-aminophenyl)sulfonyl-azanide
sodium acetyl-(4-aminophenyl)sulfonylazanide
Sodium acetyl((4-aminophenyl)sulfonyl)amide
sodium acetyl[(4-aminophenyl)sulfonyl]azanide
Sodium albucid
Sodium N-sulfanilylacetamide
Sodium sulfacetamide
SODIUM SULFACETAMIDE(1-)
Sodium sulfacyl
Sodium sulfanilylacetamide
Sodium, N(sup 1)-acetylsulfanilamido-
Soluble sulfacetamide
Soluble sulfacyl
ST50407307
Sulamyd sodium
Sulf 10
Sulf-10 Ophthalmic
Sulfableph
Sulfacetamid natrium
Sulfacetamide (Sodium)
Sulfacetamide sodium
Sulfacetamide sodium anhydrous
Sulfacetamide sodium salt
Sulfacetamide sodium salt hydrate
Sulfacetamide Sodium, pharmaceutical secondary standard; traceable to USP, PhEur
Sulfacetamide, sodium
Sulfacetamide, sodium salt
SulfacetamideSodiumSaltHydrate
Sulfacetamidum natricum
Sulfacyl sodium
Sulfacyl sodium salt
Sulfacyl sol
Sulfacyl soluble
Sulphacetamide sodium
UNII-30760ZE777

US Patents and Regulatory Information for KLARON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharms North KLARON sulfacetamide sodium LOTION;TOPICAL 019931-001 Dec 23, 1996 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Chubb
Farmers Insurance
US Department of Justice
Teva
Julphar
Cerilliant
McKesson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.